1.A patients with the X syndrome was diagnosed in the Department of Endocrine and Diabetes in Bach Mai Hospital
Pharmaceutical Journal 1999;370(8):29-31
Recent changes in lifestyle such as high-fat diet and inactivity have promoted a metabolic disorder titled syndrome X. At the moment, it is very rare in Vietnam but the prevalence of this syndrome is going to significantly increases in next decades. In Endocrinology and Diabetic Dept- Bach Mai Hospital, we found a 44 year-old patient, who met the basic criteria of the syndrome X: Hypertension, central obesity and high fasting serum Insulin. He has mild dyslipidemia. All members of his family, including his mother and his sister are also suffering from syndrome X with hypertension, obesity and overt diabetes mellitus. This patient was advised to have diet with caloric restriction and exercise to improve insulin resistance. He has been using gemfibrozil (Lopid) and metformin. After 2 months, he has lost 6 kilograms and felt better. His blood pressure was controlled without antihypertensive drugs
Metabolic Syndrome X
;
diagnosis
2.The authors reply: Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia.
Korean Journal of Urology 2015;56(12):847-848
No abstract available.
Humans
;
*Metabolic Syndrome X
;
*Prostatic Hyperplasia
3.Letter to the editor: Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia.
Mustafa KADIHASANOGLU ; Emin OZBEK
Korean Journal of Urology 2015;56(12):845-846
No abstract available.
Humans
;
*Metabolic Syndrome X
;
*Prostatic Hyperplasia
4."High normal" thyroid stimulating hormone: does it matter?.
The Korean Journal of Internal Medicine 2013;28(2):162-164
No abstract available.
Female
;
Humans
;
Metabolic Syndrome X/*blood
;
Thyrotropin/*blood
5.Oxidative stress, point-of-care test, and metabolic syndrome.
The Korean Journal of Internal Medicine 2014;29(1):20-22
No abstract available.
Antioxidants/*metabolism
;
Female
;
Humans
;
Male
;
Metabolic Syndrome X/*blood
6.Exosomes as the source of biomarkers of metabolic diseases.
Min Jae LEE ; Dong Ho PARK ; Ju Hee KANG
Annals of Pediatric Endocrinology & Metabolism 2016;21(3):119-125
Exosomes are extracellular vesicles that contain molecules that regulate the metabolic functions of adjacent or remote cells. Recent in vitro, in vivo and clinical studies support the hypothesis that exosomes released from various cell types play roles in the progression of metabolic disorders including type 2 diabetes. Based on this concept and advances in other diseases, the proteins, mRNA, microRNA and lipids in exosomes isolated from biological fluids have been proposed as biomarkers in metabolic disorders. However, several problems with the development of clinically applicable biomarkers have not been resolved. In this review, the biologic functions of exosomes are briefly introduced, and we discuss the technical and practical pros and cons of different methods of exosome isolation for the identification of exosomal biomarkers of metabolic disorders. Standardization of preanalytical variables and isolation of high-purity exosomes from fully characterized biological fluids will be necessary for the identification of useful exosomal biomarkers that can provide insights into the pathogenic mechanisms of complications of metabolic syndrome and of whole-body metabolism.
Biomarkers*
;
Diabetes Mellitus
;
Exosomes*
;
Extracellular Vesicles
;
In Vitro Techniques
;
Metabolic Diseases*
;
Metabolic Syndrome X
;
Metabolism
;
MicroRNAs
;
RNA, Messenger
7.Exosomes as the source of biomarkers of metabolic diseases.
Min Jae LEE ; Dong Ho PARK ; Ju Hee KANG
Annals of Pediatric Endocrinology & Metabolism 2016;21(3):119-125
Exosomes are extracellular vesicles that contain molecules that regulate the metabolic functions of adjacent or remote cells. Recent in vitro, in vivo and clinical studies support the hypothesis that exosomes released from various cell types play roles in the progression of metabolic disorders including type 2 diabetes. Based on this concept and advances in other diseases, the proteins, mRNA, microRNA and lipids in exosomes isolated from biological fluids have been proposed as biomarkers in metabolic disorders. However, several problems with the development of clinically applicable biomarkers have not been resolved. In this review, the biologic functions of exosomes are briefly introduced, and we discuss the technical and practical pros and cons of different methods of exosome isolation for the identification of exosomal biomarkers of metabolic disorders. Standardization of preanalytical variables and isolation of high-purity exosomes from fully characterized biological fluids will be necessary for the identification of useful exosomal biomarkers that can provide insights into the pathogenic mechanisms of complications of metabolic syndrome and of whole-body metabolism.
Biomarkers*
;
Diabetes Mellitus
;
Exosomes*
;
Extracellular Vesicles
;
In Vitro Techniques
;
Metabolic Diseases*
;
Metabolic Syndrome X
;
Metabolism
;
MicroRNAs
;
RNA, Messenger
8.Letter to the Editor: Visceral Fat and Liver Fat as Risk Factors of Metabolic Syndrome.
Ju Hye CHUNG ; Sang Wook SONG ; Se Hong KIM
Journal of Korean Medical Science 2012;27(11):1447-1448
No abstract available.
Fatty Liver/*complications
;
Female
;
Humans
;
Intra-Abdominal Fat/*anatomy & histology
;
Male
;
Metabolic Syndrome X/*etiology
9.Factors Affecting Health Promotion Behavior among Workers with High Risk of Metabolic Syndrome: Based on Theory of Planned Behavior.
Journal of Korean Academy of Community Health Nursing 2015;26(2):128-139
PURPOSE: The purpose of this study was to identify factors affecting health promotion behavior among workers with high risk of metabolic syndrome. This study was based on the planned behavior theory. METHODS: The participants were 167 workers at high risk of metabolic syndrome. Data were collected using a structured questionnaire. Surveyed variables were attitude, subjective norm, perceived behavioral control, intention, and health promotion behavior. Data were analyzed using descriptive statistics, t-test, ANOVA, Pearson's correlation coefficients, and hierarchical regression analysis with SPSS/WIN 22.0. RESULTS: Perceived behavioral control affected the intention of health promotion behavior among the workers with high risk of metabolic syndrome. It explained 62% of variance in the intention of health promotion behavior (F=40.09, p<.001). Perceived behavioral control and occupation affected health promotion behavior among the risk workers with high risk of metabolic syndrome. The two factors explained 16% of variance in health promotion behavior (F=4.95, p<.001). CONCLUSION: The findings of this study suggest that perceived behavioral control is the only factor affecting health promotion behavior when the theory of planned behavior was applied. Therefore, intervention programs for improving health promotion behavior should be focused on strengthening perceived behavioral control.
Health Behavior
;
Health Promotion*
;
Intention
;
Metabolic Syndrome X
;
Occupations
;
Surveys and Questionnaires
10.Hyperuricemia as a Novel Risk Factor for Colorectal Adenomatous Polyp.
The Korean Journal of Gastroenterology 2015;66(4):183-185
No abstract available.
Adenoma/*diagnosis
;
Colorectal Neoplasms/*diagnosis
;
Female
;
Humans
;
Male
;
Metabolic Syndrome X/*diagnosis
;
Uric Acid/*blood